cetylpyridinium chloride anhydrous and Vaginal Neoplasms

cetylpyridinium chloride anhydrous has been researched along with Vaginal Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (100.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies

Other Studies

1 other study(ies) available for cetylpyridinium chloride anhydrous and Vaginal Neoplasms

Article	Year
Most clinicians feel DES exposure does not contraindicate OC use. Contraceptive technology update, 1987, Volume: 8, Issue:10 Topics: Biology; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Contraceptives, Oral, Combined; Data Collection; Delivery of Health Care; Diethylstilbestrol; Disease; Endocrine System; Estrogens; Family Planning Services; Health; Health Personnel; Hormones; Neoplasms; Physicians; Physiology; Reproductive Control Agents; Research; Sampling Studies; Uterine Cervical Neoplasms; Vaginal Neoplasms	1987

Article

Year

Most clinicians feel DES exposure does not contraindicate OC use.

Contraceptive technology update, 1987, Volume: 8, Issue:10

Topics: Biology; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Contraceptives, Oral, Combined; Data Collection; Delivery of Health Care; Diethylstilbestrol; Disease; Endocrine System; Estrogens; Family Planning Services; Health; Health Personnel; Hormones; Neoplasms; Physicians; Physiology; Reproductive Control Agents; Research; Sampling Studies; Uterine Cervical Neoplasms; Vaginal Neoplasms

1987